November 24, 2021
1 min watch
Save
VIDEO: Results from ARIAA study presented at ACR
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Jeffrey A. Sparks, MD, MMSc, provides a review of the ARIAA study presented at ACR Convergence 2021.
According to Sparks, associate physician at Brigham and Women's Hospital, many have been “clamoring” for the results of this study, which is a prelude to the APRIPPA study, whose results are expected in 2022.
Reference:
- Rech J, et al. Abstract 0455. Presented at: ACR Convergence 2021; November 3-10, 2021 (virtual meeting).
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Sparks reports financial disclosures with AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Musculoskeletal and Skin Diseases, National Institute of Arthritis, Optum, Pfizer and R. Bruce and Joan M. Mickey Research Scholar Fund.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.